Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Egis reports results from pharmacological comparison of EGIS-7625 and methysergide

July 8, 1999

European Congress of Pharmacology presentation for novel 5-HT1B/1D receptor ligand NAS-438

July 8, 1999

Sibia Neurosciences licenses transcription-based assay technology to AHP

July 8, 1999

Nexell's stem cell selection systems approved for U.S. marketing

July 7, 1999

Biovation and Tanox enter agreement for antiinflammatory product development

July 7, 1999

Selective Genetics' GAM technology enhances delivery and retention of NTF gene therapy

July 6, 1999

Cambridge Combinatorial to provide chemistry services to Pfizer

July 5, 1999

Lexicon Genetics reports on new drug discovery technology

July 2, 1999

Targeted Genetics obtains exclusive rights to AAV manufacturing patent

July 2, 1999

Potent murine CCR2 receptor antagonist presented at World Congress on Inflammation

July 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...